MedPath

SUN YAT-SEN MEMORIAL HOSPITAL,SUN YAT-SEN UNIVERSITY

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

404

Active:17
Completed:51

Trial Phases

6 Phases

Early Phase 1:4
Phase 1:16
Phase 2:86
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (228 trials with phase data)• Click on a phase to view related trials

Phase 2
86 (37.7%)
Not Applicable
85 (37.3%)
Phase 3
22 (9.6%)
Phase 1
16 (7.0%)
Phase 4
15 (6.6%)
Early Phase 1
4 (1.8%)

Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

Not yet recruiting
Conditions
Ovarian Cancer
Antibody-drug Conjugates
Clear Cell Adenocarcinoma of Ovary
First Posted Date
2025-09-11
Last Posted Date
2025-09-11
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
22
Registration Number
NCT07168083

A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer

Not Applicable
Not yet recruiting
Conditions
Cervical Cancer Metastatic
Cervical Cancer Recurrent
Interventions
Drug: Famitinib + Camrelizumab
First Posted Date
2025-08-27
Last Posted Date
2025-08-27
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
120
Registration Number
NCT07143292

Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study

Not Applicable
Not yet recruiting
Conditions
Oral Squamous Cell Carcinoma (OSCC)
Neoadjuvant Chemoimmunotherapy
Interventions
Drug: Preoperative neoadjuvant immunotherapy chemotherapy
Drug: Two courses of preoperative neoadjuvant immunotherapy chemotherapy
Drug: Three courses of preoperative neoadjuvant immunotherapy chemotherapy
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
70
Registration Number
NCT07137858

OPtimizing REperfusion by Intra-Arterial ThRomboLysis as Adjunct to Endovascular Treatment for Medium Vessel Occlusion

Not Applicable
Not yet recruiting
Conditions
Acute Ischemic Stroke
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
530
Registration Number
NCT07137832
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis

Not Applicable
Not yet recruiting
Conditions
Symptomatic Intracranial Atherosclerotic Stenosis
Interventions
Drug: Placebo
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
5276
Registration Number
NCT07119918
Locations
🇨🇳

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 81
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.